Social Media, Social networks, etc.: lost in vocabulary?

“In the early days, social tools (blogs, wikis and the like) tended to be called social networking or social computing but as these tools entered the corporate realm, the dominant name became social media. (…)

With so many terms, it is all a little confusing: social tools, social software, social computing, social networking, social media, social marketing, social KM, Web 2.0 and Enterprise 2.0.

In summary, taking a simplistic, tools centred view:

• Social computing or social software is the technology;
• Social tools are both technology tools, such as blogs and wikis and soft tools, such as after-action reviews and knowledge cafés;
• Social marketing is about using social tools for business development;
• Social media is about using social tools for a marketing or communication purpose;
• Social networking is about using social tools to network;
• Social KM is about using social tools for a KM purpose, such as knowledge sharing or collaboration; and
• Social business is also known as Enterprise 2.

Gurteen, David. Making sense. Inside Knowledge, Online: posted 1 Mar 2011 in Volume 14 Issue 5
http://www.ikmagazine.com/display.asp?articleid=70DE7ED5-9500-46D9-A53D-96AFBAE91EB3

SI: my definition

Science Intelligence can be defined as the combination of Technics, Methods and Tools used by an organization to watch its scientific environment, in order to maintain its level of knowledge and to face its various challenging issues.

It includes process of gathering, storing and analyzing the information. It is about making the company more innovative, more efficient, more compliant and more competitive.

 Once collected, business information and data have to be converted into intelligence and re-used to drive business decision making.

SI: basic definition

For the Pharmaceutical Industry,  Science Intelligence is

• Science Awareness (Science advances, New Drug discovery, etc.)
  +
• Technological Watch (Biotechnologies, Innovation for packaging, formulations, etc.)
  +
• Business Intelligence (Competitors monitoring, Business opportunities, etc.)
  +
• Regulatory watch (Authorities guidelines, protocols, Good practices, etc.)
  +
• Post-Marketing surveillance (clinical data, etc.)

SI: a definition

Althought scientific computing oriented, this article gave a good definition of what the concept of SI could be: “let’s coin a new phrase – science intelligence (SI). SI is close to a mirror image of business intelligence (BI). (…)The objective of SI is to conduct “smart” science that efficiently uses information resources to understand specific science domains and progress toward useful applications based on that understanding.”

Richard Hackathorn.  Science Intelligence. Can a Business Intelligence Approach Enable “Smart” Science?. Information Management Magazine, August 1, 2005. Online:
http://www.information-management.com/issues/20050801/1032139-1.html

Science Intelligence

The concept of Science Intelligence (SI) is adapted from Business Intelligence (or Competitive Intelligence).

 There is a trend in the life science industry to look at scientific information in some of the same ways as enterprises have historically looked at business intelligence “
http://mndoci.com/blog/2007/11/04/scientific-intelligence-is-business-intelligence/

•         « Scientific Intelligence » or « Science Intelligence » (SI)  (or Science Watch)

 

•         The concept of SI refers to skills, technologies, applications and practices used to help a Researcher acquire a better understanding of its scientific context. This is the action of gathering, analyzing, and applying information.

•         SI may also refer to the collected information itself, the Knowledge which is gathered.

 

•         For the Life Science industry (Pharmas, Biotech companies, etc.), scope of the SI includes:

–        Latest Science advances (novelty, update, etc.)

–        Drugs & Biologicals discovery (candidates, new indication, etc.))

–        Technological innovation (disruptive) & Business Opportunities (deals, CROs, etc.)

–        Pre-Registration constraints (Authorities guidelines, procedures)

–        Clinical data and Post-marketing follow-up (safety data, toxicology, pharmacokinetics, etc)

–        Market trends (Competitive/Business Intelligence)

–        etc.

 

•         Main information sources to build this knowledge are:

–        Literature (peer-reviewed journals)

–        Congress Proceedings and Experts opinion

–        Patents and Standards

–        Guidelines, Methods and Protocols

–        Clinical trials results

–        Scientific and Press news

–        Forums, blogs, social networks, etc.

 

•         Techniques used to stay up-to-date are:

–        Awareness alerts (Keywords, Tables of contents, etc.) by emails or RSS feeds

–        Authoritative & Filtering services reading (experts reports, literature reviews and digests, etc.)

–        Web sites monitoring (key-opinion portals, Experts’ blogs, etc.)